BP102

DRUG5 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., West China Hospital, Fudan University

Conditions

Colorectal CancerColorectal Cancer MetastaticLung NeoplasmsMetastatic Colorectal Cancer

Phase 1

SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer

Not yet recruitingNCT06373133

West China HospitalColorectal Cancer

Start: 2024-05-01End: 2026-11-01Target: 36Updated: 2024-04-18

Phase 2

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

TerminatedNCT03645876

Jiangsu HengRui Medicine Co., Ltd.Metastatic Colorectal Cancer

Start: 2018-11-08End: 2019-04-18Updated: 2019-05-10

A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

TerminatedNCT03666728

Jiangsu HengRui Medicine Co., Ltd.Lung Neoplasms

Start: 2018-11-30End: 2020-03-11Updated: 2021-03-17

SHR-1701 Combined with SHR2554 and BP102 for MCRC

Not yet recruitingNCT06679673

Fudan UniversityColorectal Cancer Metastatic

Start: 2024-12-31End: 2026-12-31Target: 20Updated: 2024-11-07

An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer

Not yet recruitingNCT07061210

Fudan UniversityColorectal Cancer Metastatic

Start: 2025-07-01End: 2027-01-01Target: 20Updated: 2025-07-11